Long-term follow up Helicobacter Pylori reinfection rate after second-line treatment: bismuth-containing quadruple therapy versus moxifloxacin-based triple therapy

被引：0
|
作者：
Min Soo Kim
Nayoung Kim
Sung Eun Kim
Hyun Jin Jo
Cheol Min Shin
Young Soo Park
Dong Ho Lee
机构：
[1] Seoul National University Bundang Hospital,Department of Internal Medicine
[2] Seoul National University College of Medicine,Department of Internal Medicine and Liver Research Institute
来源：
BMC Gastroenterology | / 13卷
关键词：
Reinfection; Quadruple; Moxifloxacin; Second-line;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] HELICOBACTER PYLORI FIRST-LINE TREATMENT WITH BISMUTH-CONTAINING QUADRUPLE THERAPY, AND SECOND-LINE LEVOFLOXACIN-BASED RESCUE OPTION, IN PATIENTS ALLERGIC TO PENICILLIN
    Gisbert, J. P.
    Barrio, J.
    Modolell, I.
    Molina-Infante, J.
    Perez-Aisa, A.
    Gisbert, J. L.
    Fernandez-Bermejo, M.
    Marcos, S.
    HELICOBACTER, 2013, 18 : 132 - 132
  • [32] Second-Line Bismuth-Containing Quadruple Therapy for Helicobacter pylori Infection: A 12-Year Study of Annual Eradication Rates
    Shin, Kiwon
    Cho, Min-Jae
    Oh, Jung-Hwan
    Lim, Chul-Hyun
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (15)
  • [33] Moxifloxacin-containing triple therapy after non-bismuth quadruple therapy failure for Helicobacter pylori infection
    Lim, Ji Hyun
    Lee, Dong Ho
    Lee, Seong Tae
    Kim, Nayoung
    Park, Young Soo
    Shin, Cheol Min
    Song, In Sung
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (46) : 13124 - 13131
  • [34] Moxifloxacin-containing triple therapy after non-bismuth quadruple therapy failure for Helicobacter pylori infection
    Ji Hyun Lim
    Dong Ho Lee
    Seong Tae Lee
    Nayoung Kim
    Young Soo Park
    Cheol Min Shin
    In Sung Song
    World Journal of Gastroenterology, 2015, (46) : 13124 - 13131
  • [35] Second-line treatment for Helicobacter pylori infection based on moxifloxacin triple therapy: a randomized controlled trial
    Bago, Josip
    Pevec, Branko
    Tomic, Monika
    Marusic, Marinko
    Bakula, Vinko
    Bago, Petra
    WIENER KLINISCHE WOCHENSCHRIFT, 2009, 121 (1-2) : 47 - 52
  • [36] Levofloxacin-containing triple therapy versus bismuth-based quadruple therapy as regimens for second line anti- Helicobacter pylori
    Seyyedmajidi, Mohamadreza
    Abbasi, Laleh
    Seyedmajidi, Seyedali
    Hosseini, Seyed Ashkan
    Ahmadi, Anahita
    Hajiebrahimi, Shahin
    Vafaeimanesh, Jamshid
    CASPIAN JOURNAL OF INTERNAL MEDICINE, 2019, 10 (02) : 211 - 216
  • [37] Comparison of the traditional triple and a new bismuth-containing quadruple therapy in the first-line eradication of Helicobacter pylori
    Varga Mate
    Dracz Lajos
    Kolbenheyer Erik
    Varga Ferenc
    Patai Arpad, V
    Solymosi Norbert
    Patai Arpad
    ORVOSI HETILAP, 2019, 160 (34) : 1340 - 1345
  • [38] Amoxicillin or tetracycline in bismuth-containing quadruple therapy as first-line treatment for Helicobacter pylori infection
    Bang, Chang Seok
    Lim, Hyun
    Jeong, Hae Min
    Shin, Woon Geon
    Choi, Jae Ho
    Soh, Jae Seung
    Kang, Ho Suk
    Yang, Young Joo
    Hong, Ji Taek
    Shin, Suk Pyo
    Suk, Ki Tae
    Lee, Jae Jun
    Baik, Gwang Ho
    Kim, Dong Joon
    GUT MICROBES, 2020, 11 (05) : 1314 - 1323
  • [39] RIFABUTIN CONTAINING TRIPLE THERAPY VS. RIFABUTIN AND BISMUTH-CONTAINING QUADRUPLE THERAPY FOR THIRD-LINE TREATMENT OF HELICOBACTER PYLORI (H. PYLORI) INFECTION
    Tavani, R.
    Ciccaglione, A. F.
    Cellini, L.
    Grossi, L.
    Di Tullio, A. M.
    Pagliaro, M.
    Cocciolillo, S.
    Sepe, A.
    Di Berardino, M.
    Marzio, L.
    DIGESTIVE AND LIVER DISEASE, 2014, 46 : S111 - S111
  • [40] Annual eradication rate of bismuth-containing quadruple therapy as second-line treatment for Helicobacter pylori infection: A 15-year prospective study at a tertiary hospital in Korea
    Yoon, Kichul
    Kim, Nayoung
    Lee, Jung Won
    Yoon, Hyuk
    Shin, Cheol Min
    Park, Young Soo
    Lee, Dong Ho
    HELICOBACTER, 2020, 25 (03)
12345